Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 174

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Expert consensus statement on the use of fractional flow reserve, intravascular ultrasound, and optical coherence tomography: A consensus statement of the society of cardiovascular angiography and interventions

Open access
Lotfi, Amir, Jeremias, Allen, Fearon, William F., Feldman, Marc D., Mehran, Roxana, Messenger, John C., Grines, Cindy L., Dean, Larry S., Kern, Morton J., Klein, Lloyd W. · 2014 · Catheterization and Cardiovascular Interventions

Abstract

The rationale for use of intracoronary physiology assessment and imaging arises from the limitations of coronary angiography, the traditional method for determining the severity of coronary stenoses. The visual assessment of percent diameter reduction has significant interobserver variability 1-3, even among experienced angiographers 4. Computer-assisted quantitative coronary angiography only marginally improves diagnostic accuracy and its estimate of functional significance 5. Fractional flow reserve (FFR) is used to determine the functional significance of a coronary stenosis 6. Intravascular ultrasound (IVUS) offers excellent visualization of intraluminal and transmural coronary anatomy. Optical coherence tomography (OCT) further improves vascular visualization. There is now persuasive evidence regarding intracoronary diagnostic lesion assessments using physiology and anatomy. These adjunctive diagnostic procedures may influence the decision for coronary revascularization, guide the performance of percutaneous coronary interventions (PCI), and optimize procedural outcomes. There are substantial long-term outcome data showing benefit associated with FFR-guided decision-making. However, these techniques are underutilized in contemporary practice: the rates of use of IVUS and FFR during PCI for intermediate coronary stenoses (40–70% diameter stenosis) are 20.3% and 6.1% respectively 7. In 2011, the ACCF/AHA/SCAI PCI guidelines 8 assigned levels of evidence for the use of these modalities in various clinical situations (Table 1). The purpose of this consensus statement is to review recent studies, to develop a consensus of how these procedures are best utilized in practice, and to support their incorporation into guideline and appropriate use documents. A trans-lesional functional assessment is an important adjunct to coronary angiography for providing an objective evaluation of stenosis severity. FFR is the ratio of mean distal coronary pressure (Pd) to mean aortic pressure (Pa) during maximum hyperemia, usually induced by adenosine i.c. bolus or i.v. infusion, and represents the percentage of normal flow across a coronary stenosis. If the patient has active obstructive airways disease, i.c. adenosine can be used safely instead of IV adenosine. Alternative pharmacologic agents include nitroprusside, dobutamine, and regadenoson. Physiologic stenosis assessment by FFR is a lesion-specific index of epicardial conductance, which is independent of the microvasculature and hemodynamic changes induced by variations in heart rate, blood pressure or myocardial contractility. The FFR threshold for detecting ischemia has been corroborated by multiple tests for myocardial ischemia and reflects the functional significance (i.e. ischemic potential) of an epicardial stenosis. To establish an ischemic threshold, FFR was validated in patients with single vessel intermediate lesions and compared with the combination of three different noninvasive stress tests 9. FFR was first validated using a cutoff value of 0.75. With further experience with the technique, investigators appreciated that by extending the cutoff value to 0.80, the sensitivity of FFR could be improved without greatly compromising the specificity. For this reason, a cutoff value of ≤0.80 was used in FAME 1 and FAME 2 and shown to be clinically valid. This is now the recommended ischemic reference standard for the invasive assessment of myocardial ischemia 10 (Fig. 1). Three prospective randomized trials have demonstrated the clinical utility of FFR. To determine the safety of deferring PCI based on nonsignificant FFR, the Percutaneous Coronary Intervention of Functionally Non-significant Stenosis (DEFER) Study 12 randomized 181 patients with stable ischemic heart disease (SIHD) with FFR ≥0.75 across an intermediate stenosis to PCI or to deferral of PCI with medical treatment. At 5-year follow-up, the deferred group had a rate of death or myocardial infarction (MI) that was less than half the rate in the PCI group. To evaluate the utility of FFR for guiding the performance of PCI, the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) trial 12 randomized 1005 patients with multivessel disease (including SIHD, unstable angina, and NSTEMI) to either FFR-guided PCI or to angiography-guided PCI. The primary outcome, the composite rate of death, MI, or repeat revascularization at 1 year, was significantly lower (13.2% vs. 18.3%, P = 0.02) in patients who received FFR-guided PCI (Fig. 2). This was due to non-significant reductions in each component of the primary endpoint and a significant reduction in the combined rate of death or MI (7.3% vs. 11.1%, P = 0.04) in the FFR-guided group. At 2-year follow-up, the combined rate of death and MI remained significantly lower. An economic evaluation verified that FFR-guided PCI is a cost-saving strategy 13, with significantly fewer stents deployed and significantly less contrast media used. Addition

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ccd.25222

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

Metadata

Authors
Lotfi, A., Jeremias, A., Fearon, W. F., Feldman, M. D., Mehran, R., Messenger, J. C., Grines, C. L., Dean, L. S., Kern, M. J., & Klein, L. W.
Venue
Catheterization and Cardiovascular Interventions
Publisher
Wiley
Published
2013-11-13
Volume
83
Issue
4
Pages
509-518
ISSN
  • 1522-1946 (ISSN-L)
  • 1522-726X
OpenAlex
W2156990362
Cited by
174
References
1
FWCI
16.17
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.